Tillotts is a leading international specialty pharmaceutical company with an established presence in Europe and in the rest of the world. Tillotts markets its own products such as Asacol™ and Entocort™ as well as in-licensed products in over 65 countries through its affiliates within Europe and a network of gastroenterology-focused partners throughout the world. Tillotts is part of the Japanese Zeria Group.

BASF Beauty Care Solutions France SAS, a subsidiary of BASF SE, is a company headquartered in Lyon, France. The firm operates as a chemical company. It was founded in 1985. Patrick Ledjam is the CEO, in this role since 2013.

Unitika Ltd. engages in the polymer and functional materials business. It operates through the following business segments: Polymer, Functional Material, Fiber, and Others. The Polymer segment manufactures and sells plastic film, resin, and non-woven cloth. The Functional Material segment handles the manufacture and sale of glass fibers. The Fiber segment deals with the manufacture and sale of various fibers such as thread, cotton, and knitted fibers. The Others segment includes environmental business, medical business, lifestyle and wellness, and real estate businesses. The company was founded on June 19, 1889 and is headquartered in Osaka, Japan.

ABIGO Medical is a pharmaceutical company. ABIGO Medical AB develops, manufactures and markets a wide range of non-prescription and prescription drugs as well as an assortment of medical devices in advanced wound care and ears, nose, throat (ÖNH). In addition, foods are marketed for special medical purposes.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Quest Products has evolved over the years into a multi-faceted CPG company managing wholly owned brands, distributing over 100 national brands, selling to retail and online stores, and managing Quest owned retail websites. Quest operates several online retail stores for their own brands and those they distribute under their Powered by Quest banner. On Powered by Quest sites, shoppers can select from thousands of quality and innovative items through one checkout process. Quest Products has been ranked by INC Magazine as one of the fastest growing companies for the last seven years (2008-2014).

Nogra Pharma Ltd. operates as a pharmaceutical company. It offers brand which include Lialda and Mezavant. The firm focuses on the treatment of ulcerative colitis and crohn's disease. The company was founded in 2005 and is headquartered in Dublin, Ireland.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Markets and distributes specialty, artisanal and farmstead cheese products

FC Global Realty, Inc. engages in the acquisition, development, and management of commercial and residential real estate properties. It focuses on investments in high yield income producing assets and other opportunistic commercial properties via direct property ownership and asset management. The company was founded in 1980 and is headquartered in Willow Grove, PA.

Alnapharm AG & Co. KG is a German private company located in Hamburg specializing in pharmaceutical preparations. The firm was founded in 2010. Ali Nahavandi is the current CEO of the company.\nThe company says this about itself: The company Alnapharm AG & Co. KG is founded in July of 2010, as a sister company of Alna-Holding AG. The company develops innovative pharmaceuticals, medical devices and dietary supplements for human health. Alnapharm deals with the research and development of innovative products for the health of the people and the healing of complex health impairments. Here, the activities are not limited only to research and development. Alnapharm manufactures its own innovation and inventions and provide them worldwide. The ultimate ambition of Alnapharm is to develop products using natural resources and knowledge to meet the concept of sustainability. Great emphasis lies on the effectiveness and functionality of the developed products, so that optimal healthcare products, medical devices and pharmaceutical will arise. The first product of Alnapharm, Osvalin, a special high-quality nutritional supplement OSVALIN (www.osvalin.com) (biologically active silicone) for the prevention of osteoporosis, arthritis and general joint diseases, is available on the market since June 2014.

CinRx Pharma was launched in September of 2015 to transform the development of innovative therapies addressing substantial unmet medical needs. With leading CRO Medpace as a strategic partner, CinRx leverages its cost-efficient structure while having access to global clinical development expertise and networks of advisors, critical understanding of the evolving regulatory environment, and industry-leading track records of execution across all stages of R&D. CinRx’s therapeutic pipeline focuses on innovative and disruptive new molecular entities (NMEs). CinRx pursues an expedited path of development to achieve significant value inflection points for each of its programs. Once a compound has demonstrated clinical and commercial value, CinRx will determine the optimal strategy to bring the product to patients.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Suzhou Kehao Biological Products Co., Ltd., established on 2008-08-22, Business scope includes wholesale and retail of prepackaged food,Healthy food;Engaged in technology development in the field of biotechnology,technology transfer;cosmetic,Health food research and development,Sales;biological hair restorer,Daily necessities,household appliances,stationery,electronic product,handcrafted gift,knitted goods,Office Supplies,Clothing,Stationery,communication equipment,Labor protection supplies,Sales of chemical products and raw materials;Exhibition display service,Etiquette service;Enterprise Management Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)